Live Cell Imaging Market: By Product, By Application, By Technology, Fluorescence Recovery after Photobleaching, High Content Screening and Others), and Geography
Live Cell Imaging Market size was valued at US$ 2.8 billion in 2023 and is expected to reach a value of US$ 6.03 billion in 2030, with a CAGR of 11.6% from 2024 to 2030. The market refers to the industry involved in technologies and equipment that observe living cells in real-time using microscopy and related imaging techniques. This field is crucial for studying cellular dynamics, processes, and interactions within their natural environments, without disrupting their biological activities. The market serves a broad spectrum of applications across various fields including cell biology, neuroscience, microbiology, cancer research, drug discovery, regenerative medicine, and developmental biology, catering to diverse research needs in each domain.
The expansion of the live cell imaging market is driven by the increased use of high-content screening methods in drug discovery, the growing incidence of chronic diseases necessitating faster and more accurate diagnostic capabilities, and governmental support for research focused on cell-based approaches. Furthermore, advancements in product innovation are also fueling market expansion.
For instance, in June 2021, Leica Microsystems introduced the Leica Nano workflow, a novel solution for live-cell correlative light and electron microscopy (CLEM). This innovation aims to enhance experimental success rates, improve reproducibility, and streamline the integration of light and electron microscopy. Similarly, in January 2021, Zeiss Group launched the ZEISS Visioner 1, a cutting-edge digital microscope designed for live-cell imaging. Featuring the Micro-mirror Array Lens System (MALS), this microscope simplifies real-time focusing and aims to increase throughput. These initiatives are anticipated to drive market growth throughout the forecast period. However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals may hinder the market's growth.
Study Period
2024-2030Base Year
2023CAGR
11.6%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders has underscored the need for a deeper understanding of cellular processes. Live cell imaging provides a unique approach to observing the dynamic behaviour of living cells in real-time. Researchers utilize this technology to investigate the mechanisms underlying diseases, screen potential drug candidates, and evaluate treatment responses. In the era of personalized medicine, live cell imaging allows for the study of patient-specific cells, offering insights into disease progression and personalized therapeutic approaches.
Furthermore, biological research has made significant strides, with scientists continually uncovering new insights into cellular functions and interactions. Live cell imaging plays a crucial role in these advancements by enabling researchers to visualize dynamic cellular processes and monitor cellular behaviours over time. This capability is instrumental in studying processes such as cell division, migration, and signalling pathways, leading to breakthroughs across diverse fields including neuroscience, immunology, and regenerative medicine. As scientists strive to unravel the complexities of cellular life, live cell imaging remains an essential tool, driving its increasing demand within the market.
Based on regions the market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. In 2023, North America accounted for the largest revenue share in the live cell imaging market. The region has experienced consistent growth, largely fueled by extensive research and development initiatives. Countries like the United States and Canada host numerous leading pharmaceutical and biotechnology firms, driving significant demand for live cell imaging technologies in drug discovery and development efforts.
The Asia-Pacific region is expected to witness the most rapid growth in the live cell imaging market. This expansion is driven by burgeoning life sciences research, rising investments in healthcare infrastructure, and growing recognition of the technology's capabilities. The Asia-Pacific region is increasingly recognized as a significant participant in the global live cell imaging market, emphasizing its efforts to meet regional healthcare demands and advance scientific research.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 2.8 billion |
|
Market Size in 2030 |
US$ 6.03 billion |
|
Market CAGR |
11.6% |
|
By Product |
|
|
By Application |
|
|
By Technology |
|
Download Free Sample Report
The global live cell imaging market size was valued at US$ 2.8 billion in 2023 and is projected to grow at a CAGR of 11.8% by 2024-2030.
The leading players in the market of global live cell imaging are Danaher Life Sciences, Nikon Corporation, Olympus Life Sciences, GE HealthCare, Bruker, Thermo Fischer Scientific, Sartorius, Etaluma, Agilent BioTek, PerkinElmer, Zeiss, NanoEntek, Leica Microsystems, and Revvity
North America dominated the market share because of extensive research and development initiatives. Countries like the United States and Canada host numerous leading pharmaceutical and biotechnology firms, driving significant demand for live cell imaging technologies in drug discovery and development efforts.
The expansion of the live cell imaging market is driven by the increased use of high-content screening methods in drug discovery, the growing incidence of chronic diseases necessitating faster and more accurate diagnostic capabilities, and governmental support for research focused on cell-based approaches.
| 1.Executive Summary |
| 2.Global Live Cell Imaging Market Introduction |
| 2.1.Global Live Cell Imaging Market - Taxonomy |
| 2.2.Global Live Cell Imaging Market - Definitions |
| 2.2.1.Product |
| 2.2.2.Application |
| 2.2.3.Region |
| 3.Global Live Cell Imaging Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Live Cell Imaging Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Live Cell Imaging Market By Product, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Equipment |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Software |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Consumables |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Live Cell Imaging Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Cell Biology |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Developmental Biology |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Stem Cell |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Drug Discovery |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Live Cell Imaging Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Equipment |
| 8.1.2.Software |
| 8.1.3.Consumables |
| 8.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Cell Biology |
| 8.2.2.Developmental Biology |
| 8.2.3.Stem Cell |
| 8.2.4.Drug Discovery |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Equipment |
| 9.1.2.Software |
| 9.1.3.Consumables |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Cell Biology |
| 9.2.2.Developmental Biology |
| 9.2.3.Stem Cell |
| 9.2.4.Drug Discovery |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 10.Asia Pacific (APAC) Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Equipment |
| 10.1.2.Software |
| 10.1.3.Consumables |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Cell Biology |
| 10.2.2.Developmental Biology |
| 10.2.3.Stem Cell |
| 10.2.4.Drug Discovery |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Equipment |
| 11.1.2.Software |
| 11.1.3.Consumables |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Cell Biology |
| 11.2.2.Developmental Biology |
| 11.2.3.Stem Cell |
| 11.2.4.Drug Discovery |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Live Cell Imaging Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Equipment |
| 12.1.2.Software |
| 12.1.3.Consumables |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Cell Biology |
| 12.2.2.Developmental Biology |
| 12.2.3.Stem Cell |
| 12.2.4.Drug Discovery |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Danaher Life Sciences |
| 13.2.2.Nikon Corporation |
| 13.2.3.Olympus Life Sciences |
| 13.2.4.GE HealthCare |
| 13.2.5.Bruker |
| 13.2.6.Thermo Fischer Scientific |
| 13.2.7.Sartorius |
| 13.2.8.Etaluma |
| 13.2.9.Agilent BioTek |
| 13.2.10.PerkinElmer |
| 13.2.11.Zeiss |
| 13.2.12.NanoEntek |
| 13.2.13.Leica Microsystems |
| 13.2.14.Revvity |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
